Close

Ratings by Goldman Sachs (Madhu Kumar)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/9/2023 Arrowhead Pharma ARWR Maintain Buy
(N/A)
 
 
  Details
5/23/2023 Cerevel Therapeutics CERE Maintain Neutral
(N/A)
 
 
  Details
5/22/2023 Krystal Biotech KRYS Maintain Buy
(N/A)
 
 
  Details
5/9/2023 Syndax Pharmaceuticals SNDX Maintain Buy
(N/A)
 
 
  Details
5/5/2023 Cytokinetics CYTK Maintain Buy
(N/A)
 
 
  Details
5/4/2023 Fulcrum Therapeutics FULC Downgrade Neutral
(Buy)
2.76
(9.44)
242.03% Details
5/4/2023 Design Therapeutics Inc DSGN Upgrade Neutral
(Sell)
6.83
(4.03)
-41% Details
5/3/2023 Arrowhead Pharma ARWR Maintain Buy
(N/A)
 
 
  Details
4/14/2023 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
3/29/2023 Arcturus Therapeutics ARCT Maintain Sell
(N/A)
 
 
  Details
3/13/2023 Fulcrum Therapeutics FULC Maintain Buy
(N/A)
 
 
  Details
3/10/2023 Fulcrum Therapeutics FULC Maintain Buy
(N/A)
 
 
  Details
3/3/2023 Jazz Pharmaceuticals JAZZ Maintain Buy
(N/A)
 
 
  Details
3/2/2023 Jazz Pharmaceuticals JAZZ Maintain Sell
(N/A)
 
 
  Details
3/2/2023 Cytokinetics CYTK Maintain Buy
(N/A)
 
 
  Details
3/1/2023 Syndax Pharmaceuticals SNDX Maintain Buy
(N/A)
 
 
  Details
3/1/2023 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
2/28/2023 Krystal Biotech KRYS Upgrade Buy
(Neutral)
78.46
(98.34)
25.34% Details
2/24/2023 Dynavax Technologies DVAX Maintain Buy
(N/A)
 
 
  Details
2/23/2023 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
2/22/2023 Cerevel Therapeutics CERE Maintain Neutral
(N/A)
 
 
  Details
12/8/2022 Jazz Pharmaceuticals JAZZ Upgrade Buy
(Neutral)
151.10
(120.42)
-20.3% Details
12/8/2022 Iovanace Biotherapeutics IOVA Downgrade Neutral
(Buy)
7.26
(4.40)
-39.39% Details
11/29/2022 Cincor Pharma Inc CINC Maintain Buy
(N/A)
 
 
  Details
11/29/2022 Arrowhead Pharma ARWR Maintain Buy
(N/A)
 
 
  Details
11/28/2022 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
11/17/2022 Editas Medicine EDIT Maintain Sell
(N/A)
 
 
  Details
11/15/2022 Fulcrum Therapeutics FULC New Coverage Buy
(N/A)
7.14
(9.44)
32.21% Details
11/10/2022 Arcturus Therapeutics ARCT Maintain Sell
(N/A)
 
 
  Details
11/10/2022 Jazz Pharmaceuticals JAZZ Maintain Neutral
(N/A)
 
 
  Details
11/8/2022 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
11/7/2022 Krystal Biotech KRYS Maintain Neutral
(N/A)
 
 
  Details
11/4/2022 Dynavax Technologies DVAX Maintain Buy
(N/A)
 
 
  Details
11/3/2022 Cincor Pharma Inc CINC Maintain Buy
(N/A)
 
 
  Details
10/28/2022 Cincor Pharma Inc CINC New Coverage Buy
(N/A)
33.97
(29.06)
-14.45% Details
10/17/2022 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
9/29/2022 Jazz Pharmaceuticals JAZZ Maintain Neutral
(Neutral)
 
 
  Details
9/20/2022 Jazz Pharmaceuticals JAZZ Maintain Neutral
(N/A)
 
 
  Details
9/20/2022 Cerevel Therapeutics CERE Maintain Neutral
(N/A)
 
 
  Details
9/6/2022 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
8/25/2022 Edgewise Therapeutics EWTX Downgrade Sell
(Neutral)
10.80
(18.24)
68.89% Details
8/25/2022 Magenta Therapeutics MGTA Downgrade Neutral
(Buy)
1.75
(0.70)
-60% Details
8/25/2022 Krystal Biotech KRYS Downgrade Neutral
(Buy)
76.34
(177.93)
133.08% Details
8/9/2022 Tricida TCDA Maintain Buy
(N/A)
 
 
  Details
8/9/2022 Syndax Pharmaceuticals SNDX Maintain Buy
(N/A)
 
 
  Details
8/9/2022 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
8/8/2022 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
8/8/2022 Krystal Biotech KRYS Maintain Buy
(N/A)
 
 
  Details
8/8/2022 Myovant Sciences Ltd. MYOV Maintain Neutral
(N/A)
 
 
  Details
8/8/2022 Arrowhead Pharma ARWR Maintain Buy
(Buy)
 
 
  Details
8/5/2022 Dynavax Technologies DVAX Maintain Buy
(N/A)
 
 
  Details
8/5/2022 Arrowhead Pharma ARWR Maintain Buy
(N/A)
 
 
  Details
8/3/2022 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
7/28/2022 Myovant Sciences Ltd. MYOV Maintain Neutral
(N/A)
 
 
  Details
7/19/2022 Tricida TCDA Maintain Buy
(N/A)
 
 
  Details
7/7/2022 Arrowhead Pharma ARWR Maintain Buy
(N/A)
 
 
  Details
7/1/2022 Iovanace Biotherapeutics IOVA Maintain Buy
(N/A)
 
 
  Details
6/7/2022 Arrowhead Pharma ARWR Maintain Buy
(N/A)
 
 
  Details
5/17/2022 Magenta Therapeutics MGTA Maintain Buy
(N/A)
 
 
  Details
5/11/2022 Edgewise Therapeutics EWTX Maintain Neutral
(N/A)
 
 
  Details
5/10/2022 Reata Pharmaceuticals RETA Maintain Buy
(N/A)
 
 
  Details
5/9/2022 Syndax Pharmaceuticals SNDX Maintain Buy
(N/A)
 
 
  Details
5/5/2022 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
5/5/2022 Jazz Pharmaceuticals JAZZ Maintain Neutral
(N/A)
 
 
  Details
5/5/2022 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
5/4/2022 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
4/13/2022 Tricida TCDA New Coverage Buy
(N/A)
9.64
(0.11)
-98.86% Details
4/13/2022 Alector Inc. ALEC New Coverage Sell
(N/A)
12.28
(6.02)
-50.98% Details
4/6/2022 Jazz Pharmaceuticals JAZZ Downgrade Neutral
(Buy)
160.73
(151.10)
-5.99% Details
3/24/2022 Reata Pharmaceuticals RETA New Coverage Buy
(N/A)
37.09
(172.36)
364.71% Details
3/15/2022 Design Therapeutics Inc DSGN Maintain Sell
(N/A)
 
 
  Details
3/8/2022 Magenta Therapeutics MGTA Maintain Buy
(N/A)
 
 
  Details
3/3/2022 Passage Bio Inc. PASG Maintain Neutral
(N/A)
 
 
  Details
3/2/2022 Syndax Pharmaceuticals SNDX Maintain Buy
(N/A)
 
 
  Details
3/2/2022 Jazz Pharmaceuticals JAZZ Maintain Buy
(N/A)
 
 
  Details
3/1/2022 Horizon Therapeutics HZNP Maintain Buy
(N/A)
 
 
  Details
3/1/2022 Cerevel Therapeutics CERE Maintain
(Neutral)
 
 
  Details
3/1/2022 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
3/1/2022 Arcturus Therapeutics ARCT Maintain Sell
(N/A)
 
 
  Details
3/1/2022 Dynavax Technologies DVAX Maintain Buy
(N/A)
 
 
  Details
2/28/2022 Arvinas Inc. ARVN Maintain Buy
(N/A)
 
 
  Details
2/28/2022 Krystal Biotech KRYS Maintain Buy
(N/A)
 
 
  Details
2/25/2022 Iovanace Biotherapeutics IOVA Maintain Buy
(N/A)
 
 
  Details
2/24/2022 Editas Medicine EDIT Maintain Sell
(N/A)
 
 
  Details
2/15/2022 Cerevel Therapeutics CERE New Coverage Neutral
(N/A)
30.63
(42.27)
38% Details
2/15/2022 Syndax Pharmaceuticals SNDX New Coverage Buy
(N/A)
14.98
(23.80)
58.88% Details
1/28/2022 Edgewise Therapeutics EWTX New Coverage Neutral
(N/A)
14.00
(18.24)
30.29% Details
1/28/2022 Cytokinetics CYTK New Coverage Buy
(N/A)
30.24
(35.85)
18.55% Details
1/19/2022 Arrowhead Pharma ARWR New Coverage Buy
(N/A)
57.81
(28.60)
-50.53% Details
1/19/2022 Passage Bio Inc. PASG New Coverage Neutral
(N/A)
5.76
(1.35)
-76.56% Details
1/19/2022 TCR2 Therapeutics TCRR New Coverage Neutral
(N/A)
4.01
(1.48)
-63.09% Details
1/19/2022 Design Therapeutics Inc DSGN New Coverage Sell
(N/A)
15.85
(4.03)
-74.57% Details
1/19/2022 Arvinas Inc. ARVN New Coverage Buy
(N/A)
67.42
(41.28)
-38.77% Details
1/6/2022 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
1/6/2022 Dynavax Technologies DVAX New Coverage Buy
(N/A)
13.40
(12.41)
-7.39% Details
1/6/2022 Magenta Therapeutics MGTA Upgrade Buy
(Neutral)
4.77
(0.70)
-85.32% Details
11/29/2021 Krystal Biotech KRYS Maintain Buy
(N/A)
 
 
  Details
11/19/2021 Jazz Pharmaceuticals JAZZ New Coverage Buy
(N/A)
133.09
(120.42)
-9.52% Details
11/19/2021 Horizon Therapeutics HZNP Upgrade Buy
(Neutral)
108.08
(116.30)
7.61% Details
11/12/2021 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
11/10/2021 Dicerna Pharmaceuticals DRNA Maintain Neutral
(N/A)
 
 
  Details
11/9/2021 Arcturus Therapeutics ARCT Maintain Sell
(N/A)
 
 
  Details
11/5/2021 Iovanace Biotherapeutics IOVA Maintain Buy
(N/A)
 
 
  Details
10/27/2021 Myovant Sciences Ltd. MYOV Maintain Neutral
(N/A)
 
 
  Details
9/13/2021 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
8/27/2021 Applied Therapeutics APLT Downgrade Sell
(Neutral)
17.44
(6.80)
-61.01% Details
8/20/2021 Myovant Sciences Ltd. MYOV New Coverage Neutral
(N/A)
20.97
(26.98)
28.66% Details
8/20/2021 Magenta Therapeutics MGTA New Coverage Neutral
(N/A)
6.16
(4.77)
-22.56% Details
8/11/2021 Dicerna Pharmaceuticals DRNA Downgrade Neutral
(Buy)
23.83
(38.22)
60.39% Details
8/11/2021 Arcturus Therapeutics ARCT Downgrade Sell
(Neutral)
48.24
(33.77)
-30% Details
8/10/2021 Krystal Biotech KRYS Maintain Buy
(N/A)
 
 
  Details
8/6/2021 Dicerna Pharmaceuticals DRNA Maintain Buy
(N/A)
 
 
  Details
8/6/2021 Dynavax Technologies DVAX New Coverage Buy
(N/A)
9.88
(13.40)
35.63% Details
7/20/2021 Krystal Biotech KRYS Upgrade Buy
(Neutral)
61.09
(177.93)
191.26% Details
6/25/2021 Arcturus Therapeutics ARCT New Coverage Neutral
(N/A)
34.03
(33.77)
-0.76% Details
6/25/2021 Applied Therapeutics APLT New Coverage Neutral
(N/A)
25.04
(17.44)
-30.35% Details
5/21/2021 Iovanace Biotherapeutics IOVA Maintain Buy
(N/A)
 
 
  Details
5/19/2021 Iovanace Biotherapeutics IOVA Maintain Buy
(Buy)
 
 
  Details
5/17/2021 Apellis Pharmaceuticals APLS Maintain Buy
(N/A)
 
 
  Details
5/13/2021 Editas Medicine EDIT Maintain Sell
(N/A)
 
 
  Details
5/10/2021 Krystal Biotech KRYS Maintain Neutral
(N/A)
 
 
  Details
4/16/2021 Editas Medicine EDIT New Coverage Sell
(N/A)
41.53
(7.42)
-82.13% Details
4/16/2021 Iovanace Biotherapeutics IOVA New Coverage Buy
(N/A)
29.99
(7.26)
-75.79% Details
4/16/2021 Dicerna Pharmaceuticals DRNA New Coverage Buy
(N/A)
27.83
(38.22)
37.33% Details
4/16/2021 Apellis Pharmaceuticals APLS New Coverage Buy
(N/A)
44.48
(46.99)
5.64% Details